$1.48
0.34% today
Nasdaq, Sep 30, 04:43 pm CET
ISIN
US98986M1036
Symbol
ZYXI

Zynex, Inc. Stock price

$1.47
-0.17 10.37% 1M
-0.73 33.18% 6M
-6.54 81.65% YTD
-6.69 81.99% 1Y
-7.90 84.31% 3Y
-13.88 90.43% 5Y
+1.31 832.15% 10Y
+0.79 116.18% 20Y
Nasdaq, Closing price Mon, Sep 29 2025
+0.02 1.38%

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$42.5m
Cash
$17.5m
Shares outstanding
30.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 11.4%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$144.8m | $96.7m
EBITDA
$-15.5m | $-17.2m
EBIT
$-20.1m | $-35.5m
Net Income
$-28.7m | $-41.3m
Free Cash Flow
$-7.7m
Growth (TTM | estimate)
Revenue
-25.2% | -49.7%
EBITDA
-244.9% | -377.7%
EBIT
-291.1% | -692.4%
Net Income
-575.3% | -1,481.3%
Free Cash Flow
-144.7%
Margin (TTM | estimate)
Gross
75.6%
EBITDA
-10.7% | -17.8%
EBIT
-13.9%
Net
-19.8% | -42.7%
Free Cash Flow
-5.3%
Financial Health
Equity Ratio
29.3%
Return on Equity
8.4%
ROCE
-166.7%
ROIC
-
Debt/Equity
47.7
More
EPS
$-0.9
FCF per Share
$-0.2
Short interest
22.4%
Employees
1k
Rev per Employee
$190.0k
Show more

Is Zynex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Zynex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Zynex, Inc. forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Zynex, Inc. forecast:

Buy
67%
Hold
33%

Financial data from Zynex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
145 145
25% 25%
100%
- Direct Costs 35 35
7% 7%
24%
110 110
30% 30%
76%
- Selling and Administrative Expenses 130 130
11% 11%
89%
- Research and Development Expense - -
-
-
-15 -15
245% 245%
-11%
- Depreciation and Amortization 4.65 4.65
2,806% 2,806%
3%
EBIT (Operating Income) EBIT -20 -20
291% 291%
-14%
Net Profit -29 -29
575% 575%
-20%

In millions USD.

Don't miss a Thing! We will send you all news about Zynex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zynex, Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
NEW YORK, Sept. 27, 2025 (GLOBE NEWSWIRE) -- What's Happening: Bragar Eagel & Squire, P.C.
Neutral
GlobeNewsWire
21 days ago
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.
Positive
Proactive Investors
about one month ago
Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new CEO, along with the appointment of several senior leaders. The company announced back in June that Dyson had been selected as incoming CEO.
More Zynex, Inc. News

Company Profile

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Head office United States
CEO Thomas Sandgaard
Employees 1,000
Founded 1996
Website www.zynex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today